Healthtech Series A Investors & VC Firms
2210 firms in this list, with a median first check of $500K. 526 of them lead rounds. Generated from verified public data and updated continuously.
DLF Venture
BrusselsSeed–Series A
4 people
Alpha Square Group
New YorkSeries A–Series B
Crossroads Health Ventures
IndianapolisPre-Seed–Series A
6 people
Korify Capital
Series A–Late Stage
3 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
SBCVC
TortolaSeed–Late Stage
6 people
Bluesky Equities Ltd.
CalgaryPre-Seed–Series A
8 people
Catalpa Ventures
GrevenmacherPre-Seed–Series A$330K – $1.6M
5 people
Fika Ventures
Culver CitySeed–Series A$250K – $2M
8 people
Globalive Capital
TorontoPre-Seed–Growth
8 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
5 people
Health2047 Capital Partners LLC
Menlo ParkSeed–Late Stage
5 people
Improve Ventures
BarcelonaPre-Seed–Series A$100K – $1M
5 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
Mubadala Capital
LondonSeries A–Late Stage$1M – $50M
5 people
NewMargin Ventures
ShanghaiPre-Seed–Late Stage$425K – $200M
5 people
Sandpiper Ventures
HalifaxPre-Seed–Series A$365K
8 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Vespucci Partners
BudapestSeed–Series A$648K – $4.9M
5 people
Han River Partners
Seed–Series A
2 people
TRICAPITAL
Scottish BordersSeed–Growth$315K – $2.5M
2 people
Urania Ventures
BerlinSeed–Late Stage
2 people
Pente Capital
LondonSeed–Series A
1 person
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)Healthtech Investors & VC Firms (3208)SaaS Series A Investors & VC Firms (2667)Healthtech Seed Investors & VC Firms (2488)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Series A Investors & VC Firms in Global (2163)Consumer Series A Investors & VC Firms (1652)
Data sourced from public filings and firms' own websites — see our methodology.










































